A Dark Horse Five Years In The Making: Legend Gains First Global Approval

First 'Made in China' Cell Therapy In US

Nanjing Legend gains FDA approval for its BCMA cell therapy, the second to go to market in the US marks a win for true innovators from China, not cheaper but similar products, some say.

Cars in road race
LEGEND'S CARVYKTI RACES TO BECOME SECOND BAMA CAR-T THERAPY IN THE US • Source: Shutterstock/ParabolStudio

It’s June 2017 in Chicago, when a little-known Chinese pharma company from Nanjing published clinical study results for its cancer cell therapy then being developed domestically. The results were so shocking, achieving a 100% overall response rate, that they sealed the firm's subsequent fate.

Soon, global partners started knocking on the door and US pharma giant Johnson & Johnson quickly signed a development deal,

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Focus On Asia